New York facility plans new building and seeks faculty members.
A research institute at the State University of New York in Albany is focusing on the use of RNA to create therapeutics for conditions such as breast cancer, drug-resistant tuberculosis and HIV, depression and neurofibromatosis. Launched on 4 June, the RNA Institute won't officially open its facilities, which will include 1,400 square metres of lab space, for 18 months. But it is already recruiting, including up to six faculty researchers and two dozen postdocs with backgrounds in cell, molecular or structural biology and nuclear magnetic resonance imaging, says founding director Paul Agris. The university has invested US$12.5 million in the institute, which will employ up to 60 researchers and other staff.
Related links
Related links
Related links in Nature Research
Graduate Journal: Time to explore new worlds
Nikolaus Rajewsky, head of bioinformatics research, Max Delbrück Center, Berlin, Germany
Existence of RNA 'dark matter' in doubt
Related external links
Rights and permissions
About this article
Cite this article
RNA Institute launched. Nature 465, 969 (2010). https://doi.org/10.1038/nj7300-969c
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7300-969c